Cecilia Taverna

Dr. Cecilia Taverna

Surgical Pathology, Azienda Sanitaria Locale, Alessandria, Italy
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2022 in Cancers
Verified
Journal Article
Open access
PDF file
CTCecilia Taverna
Cecilia Taverna
Abbas AgaimyAbbas Agaimy
Abbas Agaimy
Alessandro FranchiAlessandro Franchi
Alessandro Franchi
Sinonasal carcinomas are a heterogeneous group of rare tumors, often with high-grade and/or undifferentiated morphology and aggressive clinical course. In recent years, with increasing molecular testing, unique sinonasal tumor subsets have been identified based on specific genetic alterations, including protein expression, chromosomal translocations, specific gene mutations, or infection by oncogenic viruses. These include, among others, the identification of a subset of sinonasal carcinomas associated with HPV infection, the identification of a subset of squamous cell carcinomas with EGFR alterations, and of rare variants with chromosomal translocations (DEK::AFF2, ETV6::NTRK and others). The group of sinonasal adenocarcinomas remains very heterogeneous at the molecular level, but some recurrent and potentially targetable genetic alterations have been identified. Finally, poorly differentiated and undifferentiated sinonasal carcinomas have undergone a significant refinement of their subtyping, with the identification of several new novel molecular subgroups, such as NUT carcinoma, IDH mutated sinonasal undifferentiated carcinoma and SWI/SNF deficient sinonasal malignancies. Thus, molecular profiling is progressively integrated in the histopathologic classification of sinonasal carcinomas, and it is likely to influence the management of these tumors in the near future. In this review, we summarize the recent developments in the molecular characterization of sinonasal carcinomas and we discuss how these findings are likely to contribute to the classification of this group of rare tumors, with a focus on the potential new opportunities for treatment.

10 April 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Irene RosaIrene Rosa
Irene Rosa
CTCecilia Taverna
Cecilia Taverna
LNLuca Novelli
Luca Novelli
MMMirca Marini
Mirca Marini
LILidia Ibba-Manneschi
Lidia Ibba-Manneschi
Mirko ManettiMirko Manetti
Mirko Manetti
Telocytes have recently emerged as unique interstitial cells defined by their extremely long, thin and moniliform prolongations termed telopodes. Despite growing evidence that these cells consistently reside in the stromal compartment of various organs from human beings, studies dealing with telocytes in structures of the oral cavity are scarce. Hence, the present morphologic study was undertaken to explore for the first time the presence and specific localization of telocytes within tissues of the normal human tongue, a complex muscular organ whose main functions include taste, speech, and food manipulation in the oral cavity. Telocytes were initially identified by CD34 immunostaining and confirmed by CD34/PDGFRα double immunofluorescence and transmission electron microscopy. CD34+/PDGFRα+ telocytes were organized in interstitial meshworks either in the tongue lamina propria or in the underlying striated muscle. Lingual telocytes were immunonegative for CD31, c-kit and α-SMA. Telopodes were finely distributed throughout the stromal space and concentrated beneath the lingual epithelium and around CD31+ vessels, skeletal muscle bundles/fibers, and intramuscular nerves and ganglia. They also enveloped salivary gland units outside the α-SMA+ myoepithelial cells and delimited lymphoid aggregates. These findings establish telocytes as a previously overlooked interstitial cell population worth investigating further in the setting of human tongue pathophysiology.

1 September 2018 in Human Pathology
Verified
Journal Article
Closed access
PCPiotr Czapiewski
Piotr Czapiewski
MKMichał Kunc
Michał Kunc
AGAdam Gorczyński
Adam Gorczyński
JHJohannes Haybaeck
Johannes Haybaeck
KOKrzysztof Okoń
Krzysztof Okoń
GKGünter Klöppel
Günter Klöppel

15 September 2020 in Histopathology
Verified
Journal Article
Open access
PDF file
CTCecilia Taverna
Cecilia Taverna
MBMartina Baněčková
Martina Baněčková
MLMonica Lorenzon
Monica Lorenzon
APAnnarita Palomba
Annarita Palomba
Alessandro FranchiAlessandro Franchi
Alessandro Franchi
Abbas AgaimyAbbas Agaimy
Abbas Agaimy
Aims: Secretory carcinoma (SC) (synonym: mammary analogue secretory carcinoma) is a low‐grade salivary gland tumour that occurs in both major and minor salivary glands. SC is known for its wide morphological, architectural and immunohistochemical spectrum, which overlaps with those of several salivary gland neoplasms, including acinic cell carcinoma (AciCC) and intercalated duct‐type intraductal carcinoma (IDC) in major salivary glands, and polymorphous adenocarcinoma (PAC) in minor salivary glands. These tumours share with SC some morphological features and SOX10 immunoreactivity; also, with the exception of AciCC, they all coexpress S100 and mammaglobin.Methods and results: We compared MUC4 and mammaglobin expression in 125 salivary gland carcinomas (54 genetically confirmed SCs, 20 AciCCs, 21 PACs, and 30 IDCs) to evaluate the potential of these two markers to differentiate these entities. Moderate to strong diffuse MUC4 positivity was detected in 49 SCs (90.7%), as compared with none of the IDCs and PACs. In contrast, mammaglobin was frequently expressed in SCs (30 of 36 cases; 83.3%), IDCs (24/28; 85.7%), and PACs (7/19; 36.8%). Two of three high‐grade SCs lost MUC4 expression in the high‐grade tumour component. No significant correlation was found between MUC4 expression and the fusion variant in SC (ETV6–NTRK versus non‐ETV6–NTRK).Conclusion: The results of our study identify MUC4 as a sensitive (90.7%) and specific (100%) marker for SC, with high positive (100%) and negative (93.4%) predictive values. Thus, MUC4 may be used as a surrogate for SC in limited biopsy material and in cases with equivocal morphology.

1 August 2020 in Oral Oncology
Verified
Journal Article
Closed access
Luca Giovanni LocatelloLuca Giovanni Locatello
Luca Giovanni Locatello
CBChiara Bruno
Chiara Bruno
MPMichele Pietragalla
Michele Pietragalla
CTCecilia Taverna
Cecilia Taverna
LNLuca Novelli
Luca Novelli
OGOreste Gallo
Oreste Gallo

7 April 2020 in La radiologia medica
Verified
Journal Article
Closed access
PDF file
MPMichele Pietragalla
Michele Pietragalla
Cosimo NardiCosimo Nardi
Cosimo Nardi
LBLuigi Bonasera
Luigi Bonasera
FMFrancesco Mungai
Francesco Mungai
CTCecilia Taverna
Cecilia Taverna
SCStefano Colagrande
Stefano Colagrande